Pattern of Use of Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients in UK General Practices
Phase of Trial: Phase IV
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Rivaroxaban (Primary) ; Apixaban; Dabigatran etexilate
- Indications Stroke
- Focus Therapeutic Use
- Sponsors Bayer
- 20 Nov 2017 Planned patient number changed from 3000 to 31336.
- 20 Nov 2017 Status changed from active, no longer recruiting to completed.
- 22 Sep 2017 Planned End Date changed from 30 Aug 2017 to 30 Sep 2017.